Osamu Yokosuka

Osamu Yokosuka's AcademicInfluence.com Rankings

Osamu Yokosuka

Medical

#1918

World Rank

#2303

Historical Rank

Oncology

#100

World Rank

#104

Historical Rank

Pharmacology

#188

World Rank

#228

Historical Rank

medical Degrees

Osamu Yokosuka

Philosophy

#5655

World Rank

#8522

Historical Rank

Logic

#2897

World Rank

#3969

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Osamu Yokosuka's Degrees

PhD Pharmacology University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Osamu Yokosuka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Osamu Yokosuka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial (2017) (2452)
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan (1999) (1092)
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy (2000) (741)
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties (2006) (675)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 (2009) (541)
Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. (1991) (524)
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients (1995) (433)
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease (2003) (415)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update (2019) (360)
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. (2015) (344)
New Inuyama classification; new criteria for histological assessment of chronic hepatitis (1996) (336)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial (2019) (298)
Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival (2005) (280)
Quantification of hepatitis C virus by competitive reverse transcription—polymerase chain reaction: Increase of the virus in advanced liver disease (1993) (266)
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial. (2018) (252)
Interferon therapy prolonged life expectancy among chronic hepatitis C patients. (2002) (243)
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. (2007) (202)
The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. (2008) (201)
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial (2014) (195)
APASL consensus statements and recommendation on treatment of hepatitis C (2016) (193)
Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group. (1997) (191)
Resolution of acute hepatitis C after therapy with natural beta interferon (1991) (190)
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) (2020) (185)
The Ets Transcription Factor Spi-B Is Essential for the Differentiation of Intestinal Microfold (M) Cells (2012) (176)
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. (2018) (170)
De novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes (2013) (169)
Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. (1992) (168)
APASL consensus statements and management algorithms for hepatitis C virus infection (2012) (166)
Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. (1990) (158)
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C (2004) (158)
Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing (1990) (150)
Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization (2014) (146)
Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. (2009) (145)
Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. (1993) (140)
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. (1997) (132)
Intraductal Papillary Neoplasms of the Bile Duct (2014) (128)
Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. (1997) (125)
Hepatitis C virus NS5A inhibitors and drug resistance mutations. (2014) (123)
Bezafibrate treatment: a new medical approach for PBC patients? (2003) (119)
Precore mutations and core clustering mutations in chronic hepatitis B virus infection. (1993) (115)
New antiviral therapies for chronic hepatitis C (2010) (115)
High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease (1996) (114)
Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients (2008) (114)
Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. (2010) (112)
A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C (1994) (106)
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. (2004) (106)
Favorable prognosis of chronic hepatitis C after interferon therapy by long‐term cohort study (2003) (103)
Clinicopathological features of severe and fulminant forms of autoimmune hepatitis (2011) (102)
Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan (2003) (97)
Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA (1985) (94)
The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice (2010) (93)
Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis (2008) (92)
Disinfection potential of electrolyzed solutions containing sodium chloride at low concentrations. (2000) (91)
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease (2012) (90)
Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. (2012) (87)
Down-Regulation of Hedgehog-Interacting Protein through Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma (2008) (87)
Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma Cells (2004) (86)
Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. (2001) (84)
Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects. (1985) (84)
Duck hepatitis B virus and liver diseases. (1983) (84)
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016) (83)
Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. (2013) (82)
Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Analysis of 1063 specimens. (1985) (82)
Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. (2011) (82)
Association between severity of type A hepatitis and nucleotide variations in the 5` non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions (2002) (81)
3‐Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor‐initiating hepatocellular carcinoma cells (2012) (81)
Exosomes and Hepatocellular Carcinoma: From Bench to Bedside (2019) (78)
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma (2015) (78)
Gene Expression Profiling Reveals the Mechanism and Pathophysiology of Mouse Liver Regeneration* (2003) (78)
Methylation Status of Genes Upregulated by Demethylating Agent 5-aza-2′-Deoxycytidine in Hepatocellular Carcinoma (2007) (77)
Multidrug resistance gene (MDR‐1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection (2001) (77)
The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. (2010) (75)
Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. (2008) (74)
Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective. (2009) (74)
Liver function assessment according to the Albumin–Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma (2015) (74)
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. (2006) (73)
Hepatitis B virus RNA transcripts and DNA in chronic liver disease. (1986) (73)
Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf‐dependent and ‐independent manners in Mice (2010) (72)
Fulminant hepatic failure associated with benzbromarone treatment: A case report (2002) (72)
Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients (2006) (72)
Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma. (1985) (72)
Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing (1995) (72)
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells (2013) (71)
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners (2014) (70)
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute‐onset autoimmune hepatitis (2011) (70)
The role of TT virus infection in acute viral hepatitis (1999) (70)
Sorafenib treatment in Child–Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors (2015) (69)
Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. (2010) (68)
Procaine inhibits the proliferation and DNA methylation in human hepatoma cells (2007) (68)
Diagnostic Problems Caused by HBsAg Mutants – A Consensus Report of an Expert Meeting (2004) (66)
Detection of GBV‐C RNA in patients with non‐A‐E fulminant hepatitis by reverse‐transcription polymerase chain reaction (1997) (65)
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation (2019) (65)
Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma. (2008) (64)
Phase 1 and pharmacological trial of OPB‐31121, a signal transducer and activator of transcription‐3 inhibitor, in patients with advanced hepatocellular carcinoma (2015) (63)
Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. (1985) (62)
Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. (2014) (62)
Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer. (2011) (61)
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. (2015) (61)
Ultrasound‐guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B‐mode ultrasonography (2009) (61)
Inhibition of subgenomic hepatitis C virus RNA in Huh‐7 cells: ribavirin induces mutagenesis in HCV RNA (2004) (60)
Fas Polymorphisms Influence Susceptibility to Autoimmune Hepatitis (2005) (60)
Current role of ultrasound for the management of hepatocellular carcinoma. (2008) (59)
Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A (1997) (59)
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents (2014) (58)
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags (2016) (57)
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B (2012) (57)
Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. (2003) (57)
Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer (2013) (56)
Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years. (1999) (54)
Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. (2013) (54)
Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen. (1985) (54)
Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV amplicor monitor assay (1999) (54)
Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer. (2007) (53)
Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. (2011) (53)
Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. (2010) (53)
Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities. (2003) (52)
Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology (2016) (52)
Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. (1996) (52)
Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. (2012) (51)
Efficacy of Intravenous Glycyrrhizin in the Early Stage of Acute Onset Autoimmune Hepatitis (2011) (50)
Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment (2018) (50)
Identification and investigation of methylated genes in hepatoma. (2005) (50)
The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice. (2011) (49)
Transmission of Duck Hepatitis B Virus from Chinese Carrier Ducks to Japanese Ducklings: A Study of Viral DNA in Serum and Tissue (1984) (49)
LBA-03Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial (2016) (49)
Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma (2005) (49)
Integration of hepatitis b virus dna in hepatocellular carcinoma (1986) (48)
Clinical outcomes of endoscopic resection for nonampullary duodenal high-grade dysplasia and intramucosal carcinoma (2013) (48)
Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer (2011) (48)
Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-up. (2004) (48)
Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B (2008) (48)
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update (2012) (46)
Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib (2018) (46)
Autoimmune fulminant liver failure in adults: Experience in a Japanese center (2011) (46)
Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure (2012) (46)
A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization (2018) (45)
Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease. (1985) (45)
Genome‐wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population (2017) (45)
Gene expression profiles in liver regeneration with oval cell induction. (2004) (44)
Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. (2011) (44)
Systemic inflammatory response syndrome in acute‐on‐chronic liver failure: Relevance of ‘golden window’: A prospective study (2017) (44)
Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. (2011) (43)
Non‐A, non‐B chronic hepatitis is chronic hepatitis C: A sensitive assay for detection of hepatitis C virus RNA in the liver (1992) (43)
Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure (2013) (43)
Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding (2012) (43)
Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon. (1997) (43)
Pathophysiology of Portal Hypertension and Esophageal Varices (2012) (43)
Adsorption of hepatitis C virus particles onto the dialyzer membrane. (2008) (43)
Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post‐endoscopic submucosal dissection: A propensity score‐matching analysis (2017) (42)
Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. (1991) (42)
The FLS (Fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis (2013) (42)
Efficacy of high‐dose corticosteroid in the early stage of viral acute liver failure (2014) (42)
Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines (2012) (41)
Interference of hepatitis A virus replication by small interfering RNAs. (2004) (41)
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma (2011) (41)
Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence (2011) (41)
Current management of patients with hepatocellular carcinoma. (2015) (41)
Clinical utility of intraductal US to decrease early recurrence rate of common bile duct stones after endoscopic papillotomy (2008) (41)
Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients (2000) (41)
Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. (2010) (40)
Downregulation of microRNA-431 by human interferon-β inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6. (2014) (40)
Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study (2015) (39)
Virological Escape in HCV Genotype-1-Infected Patients Receiving Daclatasvir plus Ribavirin and Peginterferon Alfa-2A or Alfa-2B (2014) (39)
Inactivation of a hepadnavirus by electrolysed acid water. (2000) (39)
Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. (2004) (39)
Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection (1987) (39)
Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. (2014) (39)
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines (2017) (39)
Advanced histology and impaired liver regeneration are associated with disease severity in acute‐onset autoimmune hepatitis (2011) (39)
HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice. (2000) (38)
Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. (2019) (38)
Nationwide survey for acute liver failure and late-onset hepatic failure in Japan (2018) (38)
Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn’s disease (2012) (38)
Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis (2016) (38)
Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer (2014) (37)
Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis. (2014) (37)
Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. (2010) (37)
Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct (2010) (37)
Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial (2017) (37)
Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment (2014) (37)
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience (2016) (37)
GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis. (1997) (37)
Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib (2016) (37)
Sustained virologic response achieved after curative treatment of hepatitis C virus‐related hepatocellular carcinoma as an independent prognostic factor (2015) (36)
Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine (2018) (36)
Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients (2011) (36)
Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA (1999) (36)
Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site. (2005) (36)
Serum osteopontin levels in patients with acute liver dysfunction (2006) (36)
Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression. (2004) (36)
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma (2017) (35)
Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. (2005) (35)
Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status (1999) (35)
Factors Associated with Inadequate Tissue Yield in EUS-FNA for Gastric SMT (2011) (35)
Hepatitis C virus protease inhibitor-resistance mutations: our experience and review. (2013) (35)
The androgen receptor as an emerging target in hepatocellular carcinoma (2015) (34)
Preoperative assessment of longitudinal extension of cholangiocarcinoma with peroral video‐cholangioscopy: A prospective study (2014) (34)
Correlation of hepatitis B virus DNA and antigens in the liver. A study in chronic liver disease. (1987) (34)
Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B (2006) (34)
Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. (2012) (34)
Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. (2009) (34)
Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. (2010) (34)
A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (2015) (34)
Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. (2015) (34)
Infection of human hepatocyte cell lines with hepatitis C virus in vitro (1995) (34)
Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. (2013) (34)
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial (2017) (33)
Antiproliferative action of metformin in human lung cancer cell lines. (2012) (33)
Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016 (2016) (32)
Changes in Tumor Vascularity Depicted by Contrast-Enhanced Ultrasonography as a Predictor of Chemotherapeutic Effect in Patients With Unresectable Pancreatic Cancer (2009) (32)
Randomized, double‐blind, placebo‐controlled trial of bovine lactoferrin in patients with chronic hepatitis C (2006) (32)
Ultrasonography for Noninvasive Assessment of Portal Hypertension (2017) (32)
No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV (2013) (32)
Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA. (1995) (32)
Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia. (2008) (32)
Analysis of genes upregulated by the demethylating agent 5‐aza‐2′‐deoxycytidine in gastric cancer cell lines (2006) (32)
Daclatasvir Combined with Peginterferon Alfa-2A and Ribavirin in Japanese Patients Infected with Hepatitis C Genotype 1 (2014) (32)
The Two Different States of Hepatitis B Virus DNA in Asymptomatic Carriers (HBe-Antigen-Positive versus Anti-HBe-Positive Asymptomatic Carriers) (1998) (32)
HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b (2015) (31)
MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells (2015) (31)
Treatment of hepatitis C virus infection in the future (2013) (31)
SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells. (2009) (31)
Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B. (2005) (31)
Fibrocytes Are Involved in Inflammation as well as Fibrosis in the Pathogenesis of Crohn’s Disease (2014) (31)
Enzymic oxidation of unconjugated bilirubin by rat liver. (1986) (31)
Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. (2005) (31)
BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer. (2010) (30)
Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm. (2013) (30)
Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma. (2012) (29)
Preoperative diagnosis and surgical management for solid pseudopapillary neoplasm of the pancreas (2014) (29)
Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinical Assessment and Molecular Docking Simulation (2009) (29)
Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey (2018) (29)
The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B (2010) (29)
[Quantification of hepatitis C virus RNA in serum]. (2004) (29)
Long‐term cohort study of chronic hepatitis C according to interferon efficacy (2012) (29)
5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines. (2005) (29)
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? (2018) (29)
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma (2018) (28)
Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES‐dependent translation and cleaves the polypyrimidine tract‐binding protein (2009) (28)
Hepatitis B virus X protein (HBx)‐induced apoptosis in HuH‐7 cells: influence of HBV genotype and basal core promoter mutations (2004) (28)
Long-term follow-up evaluation for more than 10 years after endoscopic treatment for postoperative bile duct strictures (2010) (28)
Efficacy and safety of entecavir in nucleoside‐naive, chronic hepatitis B patients: Phase II clinical study in Japan (2009) (28)
Ten‐year long‐term results after non‐surgical management of hepatolithiasis, including cases with choledochoenterostomy (2014) (28)
Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region (2013) (28)
Proposed diagnostic criteria for acute‐on‐chronic liver failure in Japan (2018) (27)
Cholangiopancreatography troubleshooting: the usefulness of endoscopic retrieval of migrated biliary and pancreatic stents. (2009) (27)
Efforts at making the diagnosis of acute‐onset autoimmune hepatitis (2011) (27)
Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha (2010) (27)
Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine (2008) (27)
Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension (2012) (27)
Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5‐Aza‐2′‐deoxycytidine (2006) (27)
Prognostic significance of genetic alterations detected by high‐density single nucleotide polymorphism array in gastric cancer (2010) (27)
Molecular biology of hepatitis A virus: Significance of various substitutions in the hepatitis A virus genome (2000) (27)
Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection (2018) (27)
Heparin‐bridging therapy is associated with a high risk of post‐polypectomy bleeding regardless of polyp size (2017) (27)
Prospective assessment of donor blood screening for antibody to hepatitis C virus by first‐ and second‐generation assays as a means of preventing posttransfusion hepatitis (1996) (27)
State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X. (2006) (27)
Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure (2017) (27)
Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan (2016) (27)
Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009 (2011) (26)
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors (2017) (26)
A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to. (2004) (26)
Endoscopic management of unresectable malignant gastroduodenal obstruction with a nitinol uncovered metal stent: A prospective Japanese multicenter study. (2016) (26)
Current and future directions for treating hepatitis B virus infection. (2015) (26)
Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta. (2000) (26)
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs (2021) (26)
Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin (2012) (26)
Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance (2012) (26)
The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells. (2015) (26)
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma. (2014) (26)
Efficacy of Stone Density on Noncontrast Computed Tomography in Predicting the Outcome of Extracorporeal Shock Wave Lithotripsy for Patients With Pancreatic Stones (2014) (26)
Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis. (2011) (25)
Mesenteric findings of CT enterography are well correlated with the endoscopic severity of Crohn's disease. (2017) (25)
Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine (2003) (25)
N‐Nitroso‐Fenfluramine Hepatotoxicity Resembling Chronic Hepatitis (2003) (25)
Abstract 4383: Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma (2012) (25)
Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C (2005) (25)
Hemodynamic features of gastrorenal shunt: a Doppler study in cirrhotic patients with gastric fundal varices. (2008) (25)
Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology (2012) (25)
Clonality in hepatocellular carcinoma: Analysis of methylation pattern of polymorphic X–chromosome‐linked phosphoglycerate kinase gene in females (1995) (25)
Predictive factor of re‐bleeding after negative capsule endoscopy for obscure gastrointestinal bleeding: Over 1‐year follow‐up study (2014) (25)
Factors affecting the accuracy of endoscopic transpapillary sampling methods for bile duct cancer (2014) (24)
Efficacy of computed image modification of capsule endoscopy in patients with obscure gastrointestinal bleeding. (2012) (24)
Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease (2016) (24)
Prognostic relevance of apparent diffusion coefficient obtained by diffusion‐weighted MRI in pancreatic cancer (2015) (24)
Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2 (2011) (24)
Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma. (2009) (24)
Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis (2017) (24)
Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): Results of the international, randomized phase 3 RESORCE trial (2017) (24)
Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function. (2010) (24)
High recovery rate of consciousness by high‐volume filtrate hemodiafiltration for fulminant hepatitis (2018) (23)
A long-term controlled trial of endoscopic pancreatic stenting for treatment of main pancreatic duct stricture in chronic pancreatitis. (2011) (23)
Significance of Prior Hepatitis B Virus Infection in the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C (2003) (23)
Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients (2011) (23)
Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication (2011) (23)
Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine (2013) (23)
Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell. (1997) (23)
Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B (2009) (23)
State of HBV DNA in HBsAg‐negative, anti‐HCV‐positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu‐HBV DNA PCR and conventional HBV PCR (2001) (23)
PCR-SSCP Analysis of 5"-Nontranslated Region of Hepatitis A Viral RNA: (2000) (23)
Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography (2010) (22)
Hepatitis C Virus Nonstructural 5 A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4 (2011) (22)
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study (2012) (22)
Expression of p53 and p21WAF1/CIP1 Proteins in Gastric and Esophageal Cancers (Comparison with Mutations of the p53 Gene) (1998) (22)
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update (2019) (22)
The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity. (2015) (22)
Extrahepatic replication of duck hepatitis b virus: More than expected (1990) (22)
Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma (2014) (22)
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula (2012) (22)
Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer (2010) (21)
Quantification of hepatitis C virus in patients treated with peginterferon‐alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test (2011) (21)
New treatments for genotype 1 chronic hepatitis C – focus on simeprevir (2014) (21)
Expression of pre-S1, pre-S2, and C proteins in duck hepatitis B virus infection. (1988) (21)
Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma. (2008) (21)
Diagnostic value of MRCP and indications for ERCP. (2007) (21)
Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method. (1998) (21)
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography (2016) (21)
Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries (2015) (21)
Factors associated with the effect of interferon‐α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B (2015) (21)
Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus (2014) (21)
Impact of IL-28B SNPs on control of hepatitis C virus infection: a genome-wide association study (2010) (21)
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33 (2019) (20)
Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication (2017) (20)
Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma (2017) (20)
Two‐dimensional shear wave elastography with propagation‐based reliability assessment for grading hepatic fibrosis and portal hypertension (2016) (20)
Prevention of hepatitis B virus-associated liver diseases by antiviral therapy (2016) (20)
Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial (2009) (20)
Low-Dose Darbepoetin α Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection (2009) (20)
Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma (2014) (20)
Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review (2015) (20)
Endoscopic sphincterotomy combined with large balloon dilation for removal of large bile duct stones. (2012) (20)
Hepatitis A viral load in relation to severity of the infection (2011) (20)
Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. (2012) (19)
Detection and partial sequencing of hepatitis C virus RNA in the liver. (1991) (19)
Analysis of DNA polymerase reaction products for detecting hepatitis B virus in serum—comparison with spot hybridization technique (1985) (19)
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. (2013) (19)
Diagnostic value of magnetic resonance cholangiopancreatography for clinically suspicious spontaneous passage of bile duct stones (2008) (19)
Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. (2010) (19)
Enzymatic oxidation of bilirubin by intestinal mucosa. (1987) (19)
Detection of hepatitis C virus RNA in acute non-A, non-B hepatitis as an early diagnostic tool. (1993) (19)
Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients (1999) (19)
Regionally differential effects of sennoside A on spontaneous contractions of colon in mice. (2007) (19)
Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma (2007) (19)
Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long‐term follow‐up (2012) (19)
Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma (2016) (19)
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19 (2020) (19)
Inhibition of cell viability by human IFN-β is mediated by microRNA-431. (2012) (19)
Stool antigen test is a reliable method to detect Helicobacter pylori in the gastric remnant after distal gastrectomy for gastric cancer. (2010) (19)
A multicenter pilot survey to clarify the clinical features of patients with acute‐on‐chronic liver failure in Japan (2018) (19)
Enhanced sensitivity of human hepatoma cells to 5-fluorouracil by small interfering RNA targeting Bcl-2. (2005) (19)
The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma (2012) (18)
Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases (2015) (18)
Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. (2015) (18)
Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases. (2005) (18)
Early events in duck hepatitis B virus infection (1985) (18)
Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? (2019) (18)
Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients (2018) (18)
Internal ribosomal entry‐site activities of clinical isolate‐derived hepatitis A virus and inhibitory effects of amantadine (2010) (18)
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells (2016) (18)
Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha (1989) (17)
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. (2005) (17)
Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels (2011) (17)
Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure (2016) (17)
Detection of hepatitis B virus precore stop codon mutants by selective amplification method: Frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers (1995) (17)
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy (2018) (17)
Coinfection study of precore mutant and wild‐type hepatitis B‐like virus in ducklings (1994) (17)
Analysis of 5′ Nontranslated Region of Hepatitis A Viral RNA Genotype I from South Korea: Comparison with Disease Severities (2010) (17)
Delta infection in Japan: Immunohistological and immuno‐electron microscopic study of delta antigen in liver tissue (1986) (17)
Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity. (2011) (17)
Revised criteria for classification of the etiologies of acute liver failure and late‐onset hepatic failure in Japan: A report by the Intractable Hepato‐biliary Diseases Study Group of Japan in 2015 (2016) (17)
Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level (2002) (17)
Aldehyde dehydrogenase 1 is associated with recurrence‐free survival but not stem cell‐like properties in hepatocellular carcinoma (2012) (17)
Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients (2011) (17)
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus (2015) (17)
Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B (2015) (17)
Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene. (1999) (17)
On‐line hemodiafiltration or high‐flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan (2015) (17)
Preoperative drainage for distal biliary obstruction: endoscopic stenting or nasobiliary drainage? (2012) (17)
Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension (2015) (16)
Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound (2012) (16)
Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells. (2012) (16)
Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure (2012) (16)
X chromosome contribution to the genetic architecture of primary biliary cholangitis. (2021) (16)
Spontaneous disappearance of limy bile: report of a case with review of the literature. (1984) (16)
Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection (2010) (16)
Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. (2011) (16)
Contrast-enhanced harmonic EUS of pancreatic schwannoma. (2016) (16)
Survey of Hepatitis B Virus Co‐infection in Hepatitis C Virus‐infected Patients Suffering from Chronic Hepatitis and Hepatocellular Carcinoma in Japan (1999) (16)
Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry. (2014) (16)
Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities (2009) (16)
Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics (2015) (16)
Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis (2011) (16)
Distinct Roles for CXCR6+ and CXCR6− CD4+ T Cells in the Pathogenesis of Chronic Colitis (2013) (16)
Hepatitis A Virus VP3 May Activate Serum Response Element Associated Transcription (2003) (15)
Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan (2012) (15)
Sofosbuvir treatment and hepatitis C virus infection. (2016) (15)
Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction (2009) (15)
LONG‐TERM OUTCOME OF ENDOSCOPIC PAPILLOTOMY FOR CHOLEDOCHOLITHIASIS WITH CHOLECYSTOLITHIASIS (2010) (15)
Biological features and biomarkers in hepatocellular carcinoma. (2015) (15)
Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation. (2013) (15)
SEVERE HEPATOTOXICITY ASSOCIATED WITH CHINESE DIET PRODUCT ‘ONSHIDOU‐GENBI‐KOUNOU’ (2003) (15)
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis (2022) (14)
Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma (2017) (14)
Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB (2016) (14)
FET family proto-oncogene Fus contributes to self-renewal of hematopoietic stem cells. (2010) (14)
THE PREVALENCE OF TT VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS IN BRAZIL (2000) (14)
Pulmonary complications resembling Wegener's granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody. (2008) (14)
Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center (2016) (14)
Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (2012) (14)
Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver. (2015) (14)
Serum fibrinogen alpha C‐chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus (2013) (14)
Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells (2014) (14)
Evaluation of clinical usefulness of second‐generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0 (2005) (14)
Severe and fulminant hepatitis of indeterminate etiology in a Japanese center (2015) (14)
Prolonged acute hepatitis A mimicking autoimmune hepatitis. (2005) (14)
Confirmation of the antispasmodic effect of shakuyaku-kanzo-to (TJ-68), a Chinese herbal medicine, on the duodenal wall by direct spraying during endoscopic retrograde cholangiopancreatography (2009) (14)
Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody (2014) (14)
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study (2012) (14)
Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line (2013) (14)
How to characterize non‐hypervascular hepatic nodules on contrast‐enhanced computed tomography in chronic liver disease: Feasibility of contrast‐enhanced ultrasound with a microbubble contrast agent (2008) (14)
Platelet count and sustained virological response in hepatitis C treatment. (2013) (14)
Influence of Paraumbilical Vein Patency on the Portal Hemodynamics of Patients With Cirrhosis (2014) (14)
Negative capsule endoscopy for obscure gastrointestinal bleeding is closely associated with the use of low-dose aspirin (2011) (14)
Intestinal Epithelial Cells with Impaired Autophagy Lose Their Adhesive Capacity in the Presence of TNF-α (2011) (14)
Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines. (2011) (14)
Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. (2010) (14)
Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell lines. (2013) (14)
Influence of splenorenal shunt on long-term outcomes in cirrhosis (2015) (13)
Smad3 contributes to positioning of proliferating cells in colonic crypts by inducing EphB receptor protein expression. (2011) (13)
Long‐term follow‐up of patients with hepatitis B e antigen negative chronic hepatitis B (2011) (13)
Evaluation of pancreatic intraepithelial neoplasia and mucin expression in normal pancreata (2012) (13)
Sonographic and clinical features of collateral vessels at the splenic hilum in cirrhosis. (2014) (13)
Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan. (2004) (13)
Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis (2014) (13)
Expression level of sonic hedgehog correlated with the speed of gastric mucosa regeneration in artificial gastric ulcers (2014) (13)
Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1 (2011) (13)
Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses. (2000) (13)
Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase (2007) (13)
Survival by pattern of tumor progression during prior sorafenib (SOR) treatment in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial comparing second-line treatment with regorafenib (REG) or placebo (2017) (13)
Hepatocyte Growth Factor Inhibits Anoikis of Pancreatic Carcinoma Cells Through Phosphatidylinositol 3-Kinase Pathway (2011) (13)
Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin (2017) (13)
A randomized controlled trial comparing water exchange and air insufflation during colonoscopy without sedation (2016) (12)
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. (2015) (12)
Therapeutic effect of balloon-occluded retrograde transvenous obliteration for gastric varices in relation to haemodynamics in the short gastric vein. (2009) (12)
Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis (2016) (12)
Blood flow parameters in the short gastric vein and splenic vein on Doppler ultrasound reflect gastric variceal bleeding. (2010) (12)
Nucleotide sequences of 5-1-1 of hepatitis C virus in patients with chronic liver disease. (1992) (12)
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. (2002) (12)
Corticosteroid might reduce serum levels of pro‐inflammatory cytokines in fulminant hepatitis: A case series (2018) (12)
Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis (2017) (12)
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection (2014) (12)
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma (2014) (12)
Four‐day continuous gastric pH monitoring following anti‐acid secretory drug administration: cross‐over test to assess the early effects (2007) (12)
Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression. (2017) (12)
Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis. (2012) (12)
Concentrating missense mutations in core gene of hepatitis B virus (1993) (12)
Utility and Stability of Transnasal Endoscopy for Examination of the Pharynx - A Prospective Study and Comparison with Transoral Endoscopy (2013) (12)
Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress (2014) (12)
Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis. (2012) (12)
Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. (2015) (12)
Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan (2016) (11)
Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. (2015) (11)
Hepatitis C Virus and Hepatocellular Carcinoma (2013) (11)
Long‐term prognosis of patients with endoscopically treated postoperative bile duct stricture and bile duct stricture due to chronic pancreatitis (2009) (11)
Twenty‐four weeks of interferon α‐2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1 (2006) (11)
Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens. (1999) (11)
Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. (2015) (11)
Histology-Based Assessment of Sonazoid-Enhanced Ultrasonography for the Diagnosis of Liver Metastasis. (2017) (11)
Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection (2000) (11)
Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection (2018) (11)
Old age is associated with increased severity of complications in endoscopic biliary stone removal (2014) (11)
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials (2020) (11)
Current status of preoperative drainage for distal biliary obstruction. (2015) (11)
Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin (2016) (11)
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma (2013) (11)
Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma. (2013) (11)
1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (2012) (11)
Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma (2019) (10)
Autoimmune hepatitis following drug-induced liver injury in an elderly patient (2016) (10)
Roles of TT Virus Infection in Various Types of Chronic Hepatitis (2001) (10)
Sustained Viral Response Is Rarely Achieved in Patients with High Viral Load of HCV RNA by Excessive Interferon Therapy (2000) (10)
Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213). (2015) (10)
Transpancreatic precut papillotomy in patients with difficulty in selective biliary cannulation. (2011) (10)
Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B (2011) (10)
Current situation of endoscopic treatment for common bile duct stones. (2012) (10)
Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers. (2014) (10)
Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation: Effect of portal hemodynamics and longitudinal clinical course (2016) (10)
Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial (2016) (10)
Role of steroid priming in the treatment of chronic hepatitis B (2000) (10)
GB virus‐C infection among chronic haemodialysis patients: Clinical implications (1997) (10)
Is ERCP really necessary in case of suspected spontaneous passage of bile duct stones? (2009) (10)
Presence of non-hypervascular hypointense nodules on Gd-EOB-DTPA enhanced MRI in patients with hepatocellular carcinoma (2016) (10)
HBV Core Protein Enhances Cytokine Production (2015) (10)
Do high levels of viral replication contribute to fulminant hepatitis A? (2005) (10)
Temporal Abstraction and Data Mining with Visualization of Laboratory Data (2007) (10)
Acute Liver Failure Associated with Propylthiouracil in a Pregnant 26-Year-Old Woman (2013) (10)
A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms (2017) (10)
Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. (2013) (10)
Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. (2011) (10)
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens (2014) (10)
Analysis of T Cell Receptor Variable Regions and Complementarity Determining Region 3 of Infiltrating T Lymphocytes in the Liver of Patients with Chronic Type B Hepatitis (2003) (10)
[Treatment of acute hepatitis C]. (2004) (9)
Heterogeneous staining in the liver parenchyma after the injection of perflubutane microbubble contrast agent. (2012) (9)
Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma (2016) (9)
High Sustained Virologic Response Rate after Interferon Monotherapy in Japanese Hepatitis C Patients with a Low HCV RNA Titer and/or HCV Genotype 2 (2004) (9)
Faldaprevir for the Treatment of Hepatitis C (2015) (9)
Objective evaluation of visibility in virtual chromoendoscopy for esophageal squamous carcinoma using a color difference formula. (2010) (9)
Retention of the cellophane wall of a patency capsule by intestinal stenosis: a report of three cases (2016) (9)
Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center (2015) (9)
In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver. Resistance of supercoiled viral DNA. (1986) (9)
Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis. (1991) (9)
Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration (2010) (9)
Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis (2018) (9)
Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe (2016) (9)
Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules. (2012) (9)
Pre-treatment hemodynamic features involved with long-term survival of cirrhotic patients after embolization of gastric fundal varices. (2010) (9)
Fulminant hepatic failure associated with triazolam. (2002) (9)
Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients (2013) (9)
Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment. (2017) (9)
The measurement of a fibrinogen α C-chain 5.9 kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution. (2011) (9)
Successful non-surgical treatment of ruptured pyogenic liver abscess. (2013) (9)
Alanine Aminotransferase Elevation during Peginterferon Alpha-2a or Alpha-2b plus Ribavirin Treatment (2013) (9)
Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance (2015) (9)
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation (2005) (9)
Changes in Plasma Ghrelin and Serum Leptin Levels after Cisplatin-Based Transcatheter Arterial Infusion Chemotherapy for Hepatocellular Carcinoma (2013) (8)
Ultra-Deep Sequencing Analysis of the Hepatitis A Virus 5'-Untranslated Region among Cases of the Same Outbreak from a Single Source (2013) (8)
Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings. (1996) (8)
Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients. (2013) (8)
Amino acid residues of core region of hepatitis B virus. Asymptomatic carriers versus patients with liver disease (1991) (8)
Cryoglobulinaemia among maintenance haemodialysis patients and its relation to hepatitis C infection (1998) (8)
Evaluation of periesophageal nerve injury after pulmonary vein isolation using the 13C-acetate breath test (2015) (8)
High level of persistent liver injury is one of clinical characteristics in treatment‐naïve acute onset autoimmune hepatitis: experience in a community hospital (2016) (8)
Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant α-interferon for chronic non-A, non-B hepatitis (1991) (8)
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response (2018) (8)
Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1 (2013) (8)
Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues (2016) (8)
A randomized controlled trial comparing a prepackaged low‐residue diet with a restricted diet for colonoscopy preparation: the impact on the results of colonoscopy in adenoma detection (2016) (8)
Long-term outcome of the WallFlex partially covered stent for unresectable malignant biliary obstruction: a multicenter single-arm prospective study. (2013) (8)
Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. (1993) (8)
The usefulness of endoscopic transpapillary procedure in post-cholecystectomy bile duct stricture and post-cholecystectomy bile leakage. (2009) (8)
Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report (2016) (8)
Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis. (2014) (8)
Successful Interventional Treatment for Arterioportal Fistula Caused by Radiofrequency Ablation for Hepatocellular Carcinoma (2014) (8)
Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B (2011) (8)
Antiviral activity of zinc sulfate against hepatitis A virus replication (2019) (8)
Current antiviral therapies for chronic hepatitis B (2008) (8)
Hepatitis A virus genotype IA-infected patient with marked elevation of aspartate aminotransferase levels (2017) (8)
Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism. (2017) (8)
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus (2019) (7)
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research Group. (2000) (7)
Carbon dioxide‐based portography: An alternative to conventional imaging with the use of iodinated contrast medium (2010) (7)
Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis (2015) (7)
Picropodophyllin suppresses the proliferation and invasion of hepatocellular carcinoma under serum starvation. (2008) (7)
Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma (2016) (7)
Correlation of hepatitis B virus DNA and antigens in the liver (1987) (7)
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study (2016) (7)
Infection with delta agent in Japan. (1985) (7)
The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response (2011) (7)
Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities (2007) (7)
Present status of artificial liver support for acute liver failure in Japan (2012) (7)
Opportunistic infection in patients with acute liver failure (2014) (7)
Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma. (2015) (7)
Adsorptive Depletion of α4 Integrinhi- and CX3CR1hi-Expressing Proinflammatory Monocytes in Patients with Ulcerative Colitis (2010) (7)
Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies (2014) (7)
Paradoxical role of Helicobacter pylori in Gastric cancer (2014) (7)
Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin (2016) (7)
Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes. (2017) (7)
Pancreatic duct guidewire-indwelling method for patients resistant to selective biliary cannulation and usefulness of pre-cut papillotomy following unsuccessful biliary cannulation with pancreatic duct guidewire-indwelling method. (2011) (7)
Endoscopic papillary large balloon dilation for bile duct stones in elderly patients. (2015) (7)
Clinical significance of endoscopic ultrasound for gastric submucosal tumors. (2013) (7)
Can endoscopic sphincterotomy be performed safely in elderly patients aged 80 years or older with pancreatic and biliary diseases? (2013) (6)
Value of peroral cholangioscopy for mucin-producing bile duct tumor. (2008) (6)
Hepatic sarcoidosis with an increased serum level of immunoglobulin G4. (2012) (6)
Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia (2016) (6)
Rapid detection of the hepatitis B virus YMDD mutant using TaqMan-minor groove binder probes. (2008) (6)
Diagnostic utility of radiological heterogeneity in acute severe (fulminant) autoimmune hepatitis (2017) (6)
Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman. (2004) (6)
Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models (2013) (6)
Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator (2011) (6)
Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. (2013) (6)
Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction. (1998) (6)
Androgen Receptor and Hepatocellular Carcinoma (2013) (6)
Clinicopathological features in patients with hepatic graft-versus-host disease. (2005) (6)
Current management of gastric varices. (2007) (6)
Body mass index in Japanese patients with autoimmune liver disease: overweight patients with primary biliary cirrhosis tend to be asymptomatic. (2007) (6)
Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan (2013) (6)
Autoimmune hepatitis in a patient with pulmonary arterial hypertension treated with endothelin receptor antagonists. (2014) (6)
Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF (2021) (6)
Effects of inferior mesenteric vein flow in patients with cirrhosis. (2013) (6)
Presence of non‐hypervascular hypointense nodules on Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging in patients with hepatocellular carcinoma (2017) (5)
Clinical utility of peroral cholangioscopy for mucin-producing bile duct tumor. (2008) (5)
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma (2013) (5)
[Hepatitis E virus infection in Japan]. (2006) (5)
Comparing gene expression profiles in human liver, gastric, and pancreatic tissues using full-length-enriched cDNA libraries. (2003) (5)
Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma? (2014) (5)
Histological discrimination between autoimmune hepatitis and drug‐induced liver injury (2012) (5)
Short- and long-term clinical outcome after balloon-occluded retrograde transvenous obliteration: is pretreatment portal flow direction a predictive factor? (2013) (5)
Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation (2016) (5)
Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria (2015) (5)
Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: a randomized crossover study. (2013) (5)
Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B (2011) (5)
Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures (2017) (5)
Hepatic filling rate of a microbubble agent: a novel predictor of long-term outcomes in patients with cirrhosis. (2014) (5)
Letter: treatment of autoimmune acute liver failure – beyond consensus guidelines (2013) (5)
Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy (2005) (5)
Point mutation in precore region of hepatitis B virus: Sequential changes from ‘wild’ to ‘mutant' (1996) (5)
Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti‐HBe (2007) (5)
Variant in C-terminal region of intestinal alkaline phosphatase associated with benign familial hyperphosphatasaemia (2018) (5)
Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments (2019) (5)
Liver Stiffness: A Significant Relationship with the Waveform Pattern in the Hepatic Vein. (2015) (5)
Comparison of Branch Duct and Main Pancreatic Duct Mural Nodules in Intraductal Papillary Mucinous Neoplasm (2013) (5)
Child‐Pugh score is altered by the albumin measurement method (2013) (5)
Utility of unsedated transnasal endoscopy for pharyngeal observation during esophagogastroduodenoscopy. A prospective study to assess cardiopulmonary function (2013) (5)
Opportunistic infection in the patients with acute liver failure: a report of three cases with one fatality (2009) (5)
Ectopic ileal varices associated with recurrent bleeding: Report of a case (2011) (5)
Expansion of metallic mesh stent hole using a Soehendra stent retriever in multiple stenting of biliary hilar obstruction. (2008) (5)
Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis (2016) (5)
Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases. (2018) (5)
Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases (2016) (5)
Corticosteroids and lamivudine combined to treat acute severe flare‐up in a chronic hepatitis B and C patient (2004) (5)
Radiologic and histologic heterogeneity in a case of autoimmune acute liver failure. (2014) (5)
[A fatal case of a hepatitis B virus carrier with fulminant hepatic failure after cytotoxic chemotherapy for malignant lymphoma]. (1993) (5)
Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A. (2007) (5)
Quantitative Analysis of Vascular Endothelial Growth Factor in Liver Metastases from Pancreatic Carcinoma as a Predictor of Chemotherapeutic Effect and Prognosis (2008) (5)
RISK FACTORS FOR POST‐ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: PROSPECTIVE SINGLE‐INSTITUTION STUDY (2007) (5)
Potential Role of Peroral Cholangioscopy for Preoperative Diagnosis of Cholangiocarcinoma (2012) (5)
Historical, present, and future significance of corticosteroid in the treatment of acute liver failure (2014) (5)
Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation (2015) (5)
Hepatitis C virus genotypes in Myanmar. (2016) (5)
Aflatoxin and p53 abnormality in duck hepatocellular carcinoma (1995) (5)
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL) (2019) (5)
A Semi-Supervised Ensemble Learning Method for Finding Discriminative Motifs and its Application (2013) (5)
Usefulness of peroral cholangioscopy in preoperative diagnosis of intraductal papillary neoplasm of the bile duct. (2010) (5)
Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response (2011) (5)
Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature (2017) (4)
Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? (2015) (4)
Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level. (2005) (4)
Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver. (1986) (4)
Prevalence of obesity in patients with acute hepatitis; is severe obesity a risk factor for fulminant hepatitis in Japan? (2005) (4)
Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? (2015) (4)
Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter study. (2009) (4)
The Potential of Transabdominal 3D Color Doppler Ultrasonography for Diagnosis of Gastric Varices (2014) (4)
Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer (2014) (4)
Endoscopic findings of small-intestinal Epstein–Barr virus-associated T-cell lymphoproliferative disorder (2012) (4)
Change in albumin measurement method affects diagnosis of nephrotic syndrome. (2014) (4)
Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia (2014) (4)
Virtual laparoscopy: Initial experience with three-dimensional ultrasonography to characterize hepatic surface features. (2013) (4)
[Clinical feature of TTV-related hepatitis]. (1999) (4)
Non-Invasive Diagnosis of Portal Hypertensive Gastropathy: Quantitative Analysis of Microbubble-Induced Stomach Wall Enhancement. (2016) (4)
A case of leucocytoclastic vasculitis as a complication of IgG4‐related skin disease (2017) (4)
Severe diffuse duodenitis successfully treated with intravenous tacrolimus after colectomy for ulcerative colitis. (2014) (4)
Signaling Pathways Involved in Molecular Carcinogenesis of Hepatocellular Carcinoma (2012) (4)
Role of IL28B genotype in older hepatitis C virus-infected patients (2013) (4)
Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015 (2020) (4)
Natural history of postvascular‐phase iso‐enhanced lesions on the sonogram in chronic liver diseases (2014) (4)
Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma. (2013) (4)
Higher serum free glycerol levels in a group of alcoholics than in controls. (2012) (4)
Occurrence of Autoimmune Hepatitis During the Course of Primary Biliary Cirrhosis: Report of Two Cases (2006) (4)
Cold polypectomy for nonampullary duodenal adenoma (2015) (4)
A primary arterio enteric fistula with Takayasu arteritis. (2013) (4)
The application of transabdominal 3D ultrasound for the diagnosis of gastric varices: a preliminary study. (2013) (4)
Does genotype of hepatitis A virus relate to clinical characteristics of hepatitis A? (2005) (4)
Utility of placement of pancreatic duct spontaneous dislodgement stent for prevention of post-ERCP pancreatitis in patients with difficulty in selective biliary cannulation. (2011) (4)
Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? (2015) (4)
Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy (2012) (4)
Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis. (1992) (4)
Frequent detection of immunoglobulin M anti‐herpes simplex viral antibody in patients with primary biliary cirrhosis (2012) (3)
Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype (2015) (3)
Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula (2016) (3)
Corticosteroid for severe acute exacerbation of chronic hepatitis B. (2013) (3)
Well‐tolerated portal hypertension and favorable prognosis in adult patients with extrahepatic portal vein obstruction in Japan (2016) (3)
Acute Liver Injury in a Patient with Alcohol Dependence: A Case Resembling Autoimmune Hepatitis or Drug-Induced Liver Injury (2014) (3)
Mosapride Citrate Increases Postprandial Glucagon-Like Peptide-1, Insulin, and Gene Expression of Sweet Taste Receptors (2015) (3)
Hepatitis A protein VP1‐2A reduced cell viability in Huh‐7 cells with hepatitis C virus subgenomic RNA replication (2006) (3)
Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C. (2011) (3)
Contrast-enhanced US with Levovist for the diagnosis of hepatic hemangioma: time-related changes of enhancement appearance and the hemodynamic background. (2008) (3)
Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease (2015) (3)
Comprehensive Analysis of Barrett’s Esophagus: Focused on Carcinogenic Potential for Barrett’s Cancer in Japanese Patients (2020) (3)
[Treatment of acute liver failure in Japan]. (2015) (3)
Determination of nucleotide sequence of active site for catalytic properties of ADH3 genes. (1992) (3)
A Role of Renal Replacement Therapy for Acute Liver Failure (2018) (3)
New cannulation method for pancreatic duct cannulation-bile duct guidewire-indwelling method. (2011) (3)
Endoscopic papillary large balloon dilation for removal of bile duct stones. (2014) (3)
Liver Orcein Stain and Viral DNA in Duck Hepatitis B Virus Infection in Chinese Ducks and Experimentally Infected Japanese Ducklings (1984) (3)
Acute Liver Failure in an Antimitochondrial Antibody-Positive 63-Year-Old Man (2012) (3)
Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient (2013) (3)
How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? (1999) (3)
Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines (2021) (3)
Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? (2012) (3)
Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma (2013) (3)
Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma. (2008) (2)
IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase. (2013) (2)
Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B (2004) (2)
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure (2021) (2)
Absence of the AKT1 pleckstrin homology domain mutation in Japanese gastrointestinal and liver cancer patients (2008) (2)
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure (2021) (2)
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. (2009) (2)
Histological re‐evaluation of autoimmune hepatitis with acute presentation (2022) (2)
Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences (2017) (2)
Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells. (2007) (2)
Hepatitis C Infection with History of Tuberculosis in Japan: No Association with Progression of Liver Fibrosis (2004) (2)
Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure. (2015) (2)
Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of anastomotic site. (2008) (2)
S1711 Distinct Roles for Cxcr6+ and Cxcr6− CD4+ T Cells in the Pathogenesis of Chronic Colitis (2010) (2)
Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial (2017) (2)
Hyponatremia: a significant factor in a poor prognosis for cirrhosis with Child A/B after variceal eradication (2015) (2)
Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients (2014) (2)
Sustained virologic response by ledipasvir/sofosbuvir reduces the incidence of hepatocellular carcinoma in Japanese patients with HCV genotype 1 infection. - Comparison with Simeprevir with peginterferon plus ribavirin (2017) (2)
Catabolism of Bilirubin by Intestinal Mucosa (1980) (2)
Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma (2020) (2)
Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma (2015) (2)
Portal response related to shunt occlusion by balloon‐occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis (2016) (2)
Relationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis (2015) (2)
[Long-term treatment for non-A, non-B chronic hepatitis--effects on hepatitis C virus (HCV)]. (1990) (2)
Overall Survival (OS) Update: 2-year follow-up from the phase-3 RESORCE trial of Regorafenib for patients with hepatocellular carcinoma (HCC) progressing on Sorafenib (2019) (2)
[Hepatitis C virus-related hepatocellular carcinoma]. (2001) (2)
Retreatment with Peginterferon α-2a + Ribavirin in Patients Who Failed Previous Peginterferon α-2b + Ribavirin Combination Therapy (2012) (2)
Long-term effect of endoscopic injection therapy with combined cyanoacrylate and ethanol for gastric fundal varices in relation to portal hemodynamics (2010) (2)
Letter: acute liver failure of indeterminate aetiology (2018) (2)
Acute Liver Failure Occurring during the First Trimester of Pregnancy Successfully Treated with Living Donor Liver Transplantation (2013) (2)
Effects of antiviral agents on chronic hepatitis B (1992) (2)
Significance of sucrose permeability test in detecting early gastric cancer and changes of permeability after endoscopic mucosal resection. (2009) (2)
Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production. (2015) (2)
Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy (2015) (2)
Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion (1993) (2)
A case of hepatocellular carcinoma with spontaneous regression of a tumor thrombus invading the main portal trunk (2016) (2)
Hypertonic Saline-Epinephrine Local Injection Therapy for Post-Endoscopic Sphincterotomy Bleeding: Removal of Blood Clots Using Pure Ethanol Local Injection (2013) (2)
The Meanings of Mutations in and Around Pre-C/C and Pre-S/S Regions of HBV: Summary of a Specialty Session (1994) (2)
Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma (2019) (2)
Appropriate diagnostic criteria for fulminant autoimmune hepatitis. (2015) (2)
703 LONG TERM EFFICACY, SAFETY AND RESISTANCE ANALYSES OF ENTECAVIR (ETV) TREATMENT IN JAPANESE NUCLEOSIDE-NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) (2008) (2)
Histologic Assessment of Long-term Entecavir Treatment in Chronic Hepatitis B Patients (2008) (2)
Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by pancreatic duct stenting using a loop-tipped guidewire. (2016) (2)
Experimental pathology - 2 (2009) (2)
A patient with adenocarcinoma of the jejunum successfully diagnosed by preoperative endoscopy for the small intestine. (2008) (1)
Successful treatment of three elderly patients aged ≥90 years with hepatocellular carcinoma (2015) (1)
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy. (2022) (1)
Cryoglobulinemia among maintenance hemodialysis patients and its relation to hepatitis C infection (1998) (1)
Abstract A69: The novel strategy for treatment of pancreactic ductal adenocarcinoma targeting tumor microenvironment. (2013) (1)
Commentary: predicting response to ciclosporin in acute severe ulcerative colitis – authors' reply (2012) (1)
Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma (2014) (1)
Mutations in the Core Nucleotide Sequence of Hepatitis B Virus Correlate with Severe Liver Damage (1994) (1)
CXCL16-CXCR6 Signaling Accelerates Restitution of the Intestinal Epithelial Cell Layer Through Activation of RAC-1 (2011) (1)
Mo1254 Superior Healing Efficacy of a New Potassium-Competitive Acid Blocker Vonoprazan (TK-438) Than That of Proton Pump Inhibitors for Post Gastric Endoscopic Submucosal Dissection Artificial Ulcers (2016) (1)
[A case of Kaposi's sarcoma of the rectum presenting with hematochezia and rectal pain]. (2015) (1)
Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells (2014) (1)
Interferons in clinical trials (2013) (1)
Significance of non-surgical treatment in the management of locally advanced pancreatic cancer (2012) (1)
Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion (2010) (1)
Peroral cholangioscopy-guided forceps biopsy to evaluate a cicatricial stricture of the biliary duct (with video). (2015) (1)
Hepadna Viruses and Hepatocarcinogenesis (1987) (1)
[Incidence of hepatocellular carcinoma in patients treated with interferon]. (1995) (1)
[Hepatitis A virus genotypes]. (2004) (1)
Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer (2013) (1)
New tapered metallic stent for unresectable malignant hilar bile duct obstruction. (2015) (1)
Saline-enhanced ultrasonography: prediction of X-ray appearance of hepatic venography in patients with cirrhosis (2014) (1)
Endoscopy-guided laser lithotripsy for a difficult-to-crush enterolith. (2014) (1)
Gene expression profiling of laterally spreading tumors (2015) (1)
A case of infrahepatic incomplete interruption of inferior vena cava with both azygos and portal system continuation (2017) (1)
Can 0.025-inch Guidewire VisiGlideTM become a Standard in the ERCP-related Procedures? VIP Study (2014) (1)
Sequence‐motif analysis of 5′‐untranslated region of GB virus‐C in Japanese patients (2000) (1)
Chronic graft-versus-host disease complicated by acute hepatitis B. (2003) (1)
1284 CIRRHOSIS DEVELOPMENT ASSOCIATED WITH ELEVATED SERUM IGG4 IN TYPE I AUTOIMMUNE HEPATITIS (2011) (1)
[Histological assessment of the liver long after interferon treatment in patients with chronic type C hepatitis]. (1994) (1)
Functional analysis of the pre-C region of DHBV DNA: A transfection study of the pre-C frameshift-mutated DNA. (1989) (1)
[Viral factors and host factors in pathogenesis of fulminant hepatitis, type B]. (2004) (1)
Utility of endoscopic retrograde cholangiopancreatography on biliopancreatic diseases in patients with Billroth II-reconstructed stomach (2017) (1)
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC) (2022) (1)
961 Distribution of HBV genotypes and mutation in the core promoter and precore region in acute forms of liver disease in Japan (2003) (1)
Treatment of hepatitis C virus infection in the (2013) (1)
Analysis of non‐severe acute onset autoimmune hepatitis according to the presence of radiological heterogeneity (2022) (1)
Similarities and differences in the clinical features between cardia varices and esophageal varices (2014) (1)
Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study. (2013) (1)
[Structural and functional characterization of the hypervariable region in the HCV genome]. (2004) (1)
A phase I, open-label, nonrandomized trial of OPB-31121, a STAT3 inhibitor, in patients with advanced hepatocellular carcinoma (HCC). (2014) (1)
Cholangiocarcinoma Derived from Remnant Intrapancreatic Bile Duct Arising 32 Years after Congenital Choledochal Cyst Excision: A Case Report (2015) (1)
Letter: should colectomy be the end‐point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? Authors' reply (2013) (1)
Etiology, time frame and spectrum of decompensation in 6236 patients of cirrhosis liver across Asia: a multinational study from APASL ACLF Research Consortium (AARC) (2017) (1)
Detection of hepatitis C virus RNA using polymerase chain reaction. (1990) (1)
[Association between severity of hepatitis A and variations in hepatitis A viral RNA]. (2004) (1)
Su1027 Efficacy of Sitafloxacin-Based Triple Therapy for Eradication-Refractory Helicobacter Pylori and Salvage Therapy With the New Potassium-Competitive Acid Blocker Vonoprazan (2016) (1)
[Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab]. (2010) (1)
[HBeAg and HBV DNA in chronic hepatitis B]. (2011) (1)
Reimbursement policies in Asia-Pacific for chronic Hepatitis B (2009) (1)
[Clinical features of HGBV-C-related liver cancer]. (1997) (1)
[Delta infection in Japan: a serological study]. (1985) (1)
Human Hepatocellular Carcinoma ) Gene Is Frequently Hypermethylated in HAI-2 / PB ( Bikunin Hepatocyte Growth Factor Activator Inhibitor 2 / Placental (2003) (1)
Letter to the Editor: Ductular Reaction in Acute Onset Autoimmune Hepatitis (2019) (1)
[Epitopes of hepatitis B virus nucleocapsid protein]. (1995) (1)
クエン酸タモキシフェン内服中に発症した非アルコール性脂肪肝炎(NASH)の1例 (2002) (1)
[Analysis of the Rikkunshito efficacy on patients with functional dyspepsia]. (2011) (1)
Abstract A85: The exploration of novel strategy for treatment of pancreactic ductal adenocarcinoma targeting tumor microenvironment. (2012) (0)
A case of gastric varices with unusual shape and hemodynamics accompanied with polycythemia vera (2007) (0)
Sa1479 Clinical Utility of Balloon Enteroscopy Subsequent to Negative Capsule Endoscopy for Obscure Gastrointestinal Bleeding (2013) (0)
Mo1309 The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying (2014) (0)
Proceedings of the international session of the 26th annual meeting October 18–20, 1984—Chiba, Japan (2007) (0)
Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy (2017) (0)
Thirty‐two years' experience of treating fulminant hepatitis in a Japanese single center (2022) (0)
[Significance of total dose of IFN in the treatment of chronic hepatitis C]. (1994) (0)
1508: Objective Spatial Accuracy Test of Ultrasound Volume Sata in Newly Developed in DICOM Formatting System (2009) (0)
Imaging of acute pancreatitis and chronic pancreatitis: the role of transabdominal ultrasound (2007) (0)
[Detection of various HBV markers in asymptomatic HBsAg carriers--importance of sensitivity of the methods used in the setting when mother-infant transmission is possible (author's transl)]. (1981) (0)
1132 THE REPORTER INTERACTING PROTEIN-2 MIGHT PLAY AN IMPORTANT ROLE IN THE INHIBITION OF INTERLEUKIN-6 PRODUCTION BY HBE ANTIGEN (2011) (0)
[Virological diagnosis--HBV mutant, HBV subtype etc]. (1995) (0)
Cytotoxicity and gene expression induced by histone deacetylase inhibitor, trichostatin A, on human hepatoma cells (2003) (0)
Erratum to: Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis (2016) (0)
The methylation status of the CpG island of Phase 2 xenobiotic-metabolizing enzymes NQO1 and GSTP1 in human hepatocellular carcinoma (2003) (0)
1005 Estimating the benefit of interferon therapy for individual patients with chronic hepatitis (2003) (0)
[Precore/core mutation and clinical course of chronic hepatitis B virus infection from the view point of asymptomatic carriers]. (1995) (0)
Abstract A39: The exploration of novel strategy for treatment of pancreactic ductal adenocarcinoma targeting tumor microenvironment with multi-kinase inhibitors (2012) (0)
744 Ultrasound-Guided Treatments Under Low Acoustic Power Contrast Harmonic Imaging with Sonazoid Is Effective for Hepatocellular Carcinomas Undetected By B-Mode Ultrasonography (2009) (0)
Treatment of acute non-A, non-B hepatitis with interferon. (1990) (0)
THU-053-Usefulness of lactate-free Asian Pacific Association for The Study of Liver acute-on-chronic liver failure research consortium ACLF score for predicting short-term mortality in patient with alcoholic liver disease (2019) (0)
Hemophagocytic Lymphohistiocytosis (HLH) in patients of acute on chronic liver failure-Results of multination study from APASL-ACLF research consortium (AARC) (2018) (0)
Utility of DWI and FGD-PET/CT for evaluating malignancy of BD-IPMN (2016) (0)
Higher baseline MAP protects against organ failure in patients of acute on chronic liver failure (ACLF) (2018) (0)
Su1684 A Randomized Controlled Trial Comparing a Prepackaged Low-Residue Diet Versus a Restricted Diet for Colonoscopy Preparation (2015) (0)
[Clinical features of SEN virus infection]. (2004) (0)
Sa1728 The Expression Levels of Sonic Hedgehog and Il1 β Correlate With the Speed of Gastric Mucosa Regeneration (2013) (0)
P069 Glycine and glutamine down-regulate IL-6-induced claudin-2 expression in human colonic epithelial cell monolayer (2013) (0)
Multiple comet tail artifacts in the liver: a case of congenital hepatic fibrosis showing unusual biliary appearance (2014) (0)
Author's response to reviews Title:Gene Expression Profiling of Laterally Spreading Tumors Authors: (2015) (0)
A case of bile duct cancer developing 9 years after treatment of choledocholithiasis in a patient with a history of Billroth II gastrectomy (2014) (0)
A new approach for diagnosis of hepatolithiasis: magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of hepatolithiasis. (2008) (0)
Correspondence (2018) (0)
Efficacy of endoscopic-ultrasound-guided transmural drainage in patients with pancreatic pseudocysts (2013) (0)
Comparison of hepatitis B virus specific RNA, HBV DNA, and HBV antigenic proteins. (1986) (0)
THU-279-The prognostic stratification using acute-on-chronic liver failure scoring systems for predicting short-term mortality in patients with alcoholic hepatitis (2019) (0)
Favorable Outcome of Patients with C-Viral Liver Disease Treated with Interferon (2004) (0)
Contents Vol. 66, 2004 (2004) (0)
Finding HCV NS 5 A Discriminative Motifs for Assessement of IFN / Ribavarin Therapy Effect (2011) (0)
Clinical features and prognosis of advanced stage hepatocellular carcinoma; verification of diverse progression processes (2018) (0)
Nasobiliary drainage and percutaneous injection sclerotherapy with minocycline for obstructive jaundice due to polycystic liver disease : A case report (2010) (0)
Comparison of endoscopic papillary balloon dilatation and endoscopic sphincterotomy for bile duct stones. (2016) (0)
[Diagnostic tests: Serum anti-hepatitis A virus antibody and hepatitis A virus RNA]. (2005) (0)
Analysis of the Effectiveness of Sorafenib Taking into Account the Clinical Course in Patients with Hepatocellular Carcinoma (2016) (0)
T1023 The Traditional Japanese Medicine Rikkunshito Improves Upper Gastrointestinal Symptoms in Patients With Functional Dyspepsia (2010) (0)
[New antivirals for hepatitis B virus infection]. (2015) (0)
Prevention of hepatocellular carcinoma in chronic hepatitis B. (2005) (0)
S1298 Hemodynamics in the Gastrorenal Shunt On Doppler Ultrasound Reflect the Grading and Bleeding of Gastric Fundal Varices (2008) (0)
Determination of plasma prothrombin levels by a novel Ca2+-dependent prothrombin activator (CA-1) in patients with chronic liver diseases. (2004) (0)
Two patients with hepatic mucosa-associated lymphoid tissue lymphoma resembling hypervascular hepatocellular carcinoma (2015) (0)
P0786 : 100% SVR12 with ledipasvir/sofosbuvir±ribavirin for 12 weeks in Japanese patients with chronic genotype 1 hepatitis C virus who previously failed therapy with protease inhibitor + pegylated interferonα + ribavirin (2015) (0)
[History of the discovery of viral hepatitis]. (2015) (0)
[Serum anti-hepatitis A virus antibody and hepatitis A virus RNA]. (2010) (0)
Three hepatocellular carcinoma patients with pleural effusion successfully treated by pleurodesis with a view to palliative medicine (2015) (0)
CASE REPORT: Fulminant Hepatic Failure Associated with Triazolam (2002) (0)
Hepatoma and medicine medical care. The hepatoma. The setting of a high risk group. Hepatitis C virus infectious disease and hepatoma. (1995) (0)
Dexamethasone for the prevention of transcatheter arterial chemoembolization-induced fever, nausea, vomiting, and anorexia in patients with hepatocellular carcinoma: A randomized, double-blind, placebo-controlled trial. (2016) (0)
Liver transplantation. Present states and prospects. II. Treatment outcome and problems. 5. Liver cirrhosis C. (2001) (0)
[A case of steatohepatitis associated with tamoxifen]. (2002) (0)
of hepatitis B virus : effect of nucleotide substitutions on the clinical features of chronic hepatitis B (0)
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma (2018) (0)
Liver orcein stain and DHBV DNA. (1985) (0)
Impact of Aging on Liver Histological Findings of Autoimmune Liver Diseases (2014) (0)
[Mutations in precore and core nucleotide sequence of hepatitis B virus correlated with fulminant and severe hepatitis]. (1995) (0)
Molecular Aspects of Hepatocellular Carcinoma (2018) (0)
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study (2022) (0)
Anti-viral effect of rIFN-.ALPHA. 2a for hepatitic C virus. (1991) (0)
FRI-161-Complication is a major risk factor for mortality of cirrhotic hepatitis B virus-related acuted-on-chronic liver failure patients: A multi-national study from Asian-pacific region (2019) (0)
A case of asymptomatic non-cirrhotic primary biliary cholangitis showing splenorenal shunt with neither anti-mitochondrial antibody nor M2 antibody (2017) (0)
A phase I/II study of capecitabine combined with peginterferon alfa-2a in sorafenib-refractory advanced hepatocellular carcinoma patients. (2014) (0)
The Successful Use of Peroral Cholangioscopy for the Diagnosis and Treatment of the Biliary Tract Lesions and Giant Bile Duct Stones in a 76-Year-Old Man (2009) (0)
Abstract 3292: The exploration of novel strategy for treatment of pancreactic cancer using genetically engineered mice (2011) (0)
Comprehensive mutational analysis of background mucosa in patients with Lugol‐voiding lesions (2021) (0)
Contents Vol. 87, 2014 (2014) (0)
Diagnostic value of immunohistochemical IMP3 expression in EUS-FNA of pancreatic solid mass (2016) (0)
Letter to the Editor: Long-term experience of treating autoimmune hepatitis with acute presentation. (2023) (0)
Gene Expression Profiling Reveals the Mechanism and Pathophysiology of Mouse Liver Regeneration*□S (2003) (0)
Development of multidisciplinary therapy including surgical resection and chemotherapy for pancreatic cancer through clinical trials (2013) (0)
Contrast-enhanced ultrasound for non-tumor liver diseases. (2012) (0)
[Effects of adenine arabinoside on duck hepatitis B virus infection. Analysis of intrahepatic replicative DNA]. (1987) (0)
Hepatitis B Virus e Antigen Physically Associates With (2012) (0)
Clinical and histological recovery from “life-threatening” severe acute alcoholic hepatic failure with complete hepatofugal portal blood flow (2011) (0)
High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis (1993) (0)
[HLA types and their ability to present the HBV peptides]. (1995) (0)
Temporal changes in recurrent incidences after curative therapies in early stage hepatocellular carcinoma (2018) (0)
Liver transplantation for patients with acute-on-chronic liver failure in Asia (2016) (0)
Abstract 2511: Comprehensive metabolic profiling of hepatocellular carcinoma and pancreatic tumors by capillary electrophoresis-mass spectrometry. (2013) (0)
Profile of ACLF cases in Asia: A multicentre study (2018) (0)
327 Characterization of full-lenght hepatitis C viral RNA sequence in patients treated with interferon and ribavirin combination therapy (2003) (0)
Integration of duck hepatitis B virus DNA in duck hepatocellular carcinoma. State of duck hepatitis B virus DNA in liver tissue. (1986) (0)
962 Influence of HBV genotype and basal core promoter mutations to PX-induced apoptosis (2003) (0)
1170 GENETIC VARIATION NEAR THE INTERLEUKIN 28B GENE AND HEPATIC STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION (2011) (0)
18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis (2014) (0)
S1788 Glycine and Glutamine Down-Regulate IL-6-Induced Claudin-2 Expression in Human Colonic Epithelial Cell Monolayers (2010) (0)
[Recent progress in the treatment of chronic hepatitis B]. (2018) (0)
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients (2015) (0)
1) Hepatitis B Virus Infection and Hepatocellular Carcinoma (2015) (0)
Changes of HBV DNA in liver and serum by recombinant interferon treatment. (1985) (0)
Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
Mo1068 Efficacy of Rikkunshito on Anorexia in Chronic Hepatitis C Patients During PEG-IFN/RBV Therapy (2013) (0)
Tu1565 Efficacy of Computed Image Modification at Capsule Endoscopy in the Examination of Patients With Obscure Gastrointestinal Bleeding (2011) (0)
[Multiorgan infection of duck hepatitis B virus (DHBV): a mode of initiation of DHBV replication in an experimental transmission study]. (1985) (0)
Defining a ‘golden window' period and relevance of systemic inflammatory response syndrome (SIRS) in acute on chronic liver failure (ACLF) a tool for intervention and improved survival (2015) (0)
[Analysis of HCV core protein function using HCV core transgenic mice]. (2004) (0)
A pilot study on cisplatin-based transarterial chemoembolization combined with systemic cisplatin plus gemcitabine for advanced or metastatic intrahepatic cholangiocellular carcinoma. (2017) (0)
Abstracts of selected papers presented at the 76th General Meeting of the Japanese Society of Gastroenterology March 29–31, 1990, Tokyo, Japan (2007) (0)
[Analysis of the frequency of superinfection with hepatitis C virus in chronic hepatitis B virus carriers]. (1995) (0)
Supplementary Material for: Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues (2016) (0)
Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
[Features and therapy of the patients with chronic hepatitis C resistant to IFN therapy]. (1995) (0)
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. (2013) (0)
Drug-Induced Liver Injury Associated with Complementary and Alternative Medicines (2016) (0)
W1125 Characteristics of Esophageal Motility in Patients With NERD Refractory for PPIs and a Treatment Strategy Using Rikkunshito – A Study Using Combined Multichannel Intraluminal Impedance and Manometry (MII-EM): Part II (2010) (0)
[Mutations in the epsilon sequences of hepatitis B virus]. (2004) (0)
Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon/Ribavirin Therapy (2010) (0)
DOES MONOCLONALITY MEAN MALIGNANCY ? AUTHORS REPLY (1996) (0)
Effects of Let-7c on the processing of hepatitis B virus associated liver diseases (2022) (0)
Antiviral treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon. (1986) (0)
Analyses of intermediate stage hepatocellular carcinoma patients from the point of view of designing clinical trials comparing transarterial chemoembolization and systemic therapies (2018) (0)
Mo1143 Sporadic Non-Ampullary Duodenal Adenoma/Carcinoma Is Associated With Not Only Colon Adenoma/Carcinoma but Also Gastric Cancer (2014) (0)
909 Identification of up-regulated genes by histone deacetylase inhibition using CDNA microarray and association between gene expression and epigenetic alterations on hepatoma cells (2003) (0)
Improvement of Gastric Emptying in Patients With Parkinson Disease by Bilateral Deep Brain Stimulation (DBS) (2011) (0)
Flicking method: A novel colonoscope insertion method for surveillance colonoscopy in ulcerative colitis patients (2012) (0)
W1005 Contrast-Enhanced Ultrasound with Sonazoid for the Differentiation of Idiopathic Portal Hypertension from Liver Cirrhosis (2009) (0)
Sa1893 Predictive Factors of Response to Intravenous Cyclosporine in Severe Ulcerative Colitis: Development of a Novel Calculation Formula for Earlier Clinical Decision-Making (2012) (0)
Impact of organ failure in patients with acute on chronic liver failure (ACLF) and the newly defined AARC liver failure score in predicting 90 days survival-results from APASAL-ACLF research consortium (AARC) (2018) (0)
596 Development of hepatic failure was found less frequently than that of hepatocellular carcinoma in Japanese patients with chronic hepatitis C (2003) (0)
Royal Free Hospital (London)(FROM ABROAD) (1979) (0)
P.113 Anti-viral activity, histologic improvement and safety of entecavir in Japanese adult nucleoside-analogue naive patients with chronic hepatitis B infection: a phase 2 clinical trial (2006) (0)
Long-Term Follow-Up of Hepatitis B e Antigen-Negative Hepatitis B Virus Carriers according to the Status of HBV DNA and ALT Levels Fumio International Journal of Hepatology & Gastroenterology (2018) (0)
Clinical evaluation of endosonography-guided biliary drainage for patients with the difficulty with placing of internal drainage. (2009) (0)
LIVER, PANCREAS, AND BILIARY TRACT Use of F-18 Fluorodeoxyglucose Positron Emission Tomography With Dual-Phase Imaging to Identify Intraductal Papillary Mucinous Neoplasm (2013) (0)
[Association between severity of hepatitis A and variations of hepatitis A virus genome]. (2003) (0)
Letter: factors that may predict response to ciclosporin in ulcerative colitis – authors’ reply (2013) (0)
734 ASSOCIATION BETWEEN MICA POLYMORPHISM AND THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C (2012) (0)
Long-term follow-up of antiviral treatment in HBeAg positive chronic hepatitis patients (1987) (0)
[Mechanisms of hepatocarcinogenesis by hepatitis B virus(HBV) infection]. (2001) (0)
Pre-S1 and pre-S2 polypeptides in the serum of patients with B-viral chronic liver disease (1988) (0)
Carbon dioxide-based portography: an alternative to conventional imaging with the use of iodinated contrast medium: Carbon dioxide for portography (2009) (0)
Immunohistological study of delta-antigen and anti-delta in hepatitis B virus infection. (1984) (0)
Validation of TPPM Score in predicting short-term survival in HBV-ACLF patients: a multi-national study from APASL ACLF Research Consortium (AARC) (2017) (0)
[Mutations in X region gene]. (1995) (0)
TransNasal Esophagogastroduodenoscopy (TN-EGD) is Suitable for Evaluation of the Pharynx. A Prospective Study Compared With Conventional EGDS (2011) (0)
[Prognosis of patients with type B hepatitis from the view point of viral mutation(s)]. (1995) (0)
[Current status and future perspective of molecular targeted therapy for hepatocellular carcinoma]. (2009) (0)
Contents Vol. 47, 2004 (2004) (0)
Safe recovery of a fully fractured basket in the bile duct using endoscopic papillary large balloon dilation (2014) (0)
Rapid turnover rate of hepatitis C virus clearance by the twice-a-day treatment regimen using interferon-beta (2000) (0)
Mo1160 The Gene Expression of Taste Receptors in Gastrointestinal Tract After the Administration of Drugs for Functional Gastrointestinal Disorders (2012) (0)
Sa1311 Real-Time Endoscopy-Guided Measurement of Mucosal Admittance to Diagnose Mucosal Integrity in Patients With Gastroesophageal Reflux Disease (2016) (0)
Differentiation of malignant and benign IPMN by repeated pancreatic juice cytology combination with CEA level in pancreatic juice (2016) (0)
Simulationand Molecular Docking as Determined by Long-Term Clinical Hepatitis B Virus with Viral Breakthrough Mechanism of Entecavir Resistance of (2013) (0)
Subject Index Vol. 66, 2004 (2004) (0)
Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions (2008) (0)
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Viral Infection and Tumors: Hepatitis B Virus Infection and Hepatocellular Carcinoma]. (2015) (0)
A case of extrahepatic portal vein obstruction due to non-cirrhotic portal vein thrombosis with the JAK2V617F mutation (2014) (0)
Successful treatment of two patients with hepatocellular carcinoma exhibiting severe pancytopenia caused by aplastic anemia (2016) (0)
Pneumocystis jirovecii pneumonia Suspected Due to Low-Dosage Prednisolone Treatment for Acute Autoimmune Hepatitis: Case Report and Literature Review (2017) (0)
The Role of Peroral Cholangioscopy in the Management of Biliary Tract Diseases (2008) (0)
JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B (2009) (0)
[Detection of ras gene mutations of pancreatic tumors by polymerase chain reaction and direct sequencing method]. (1989) (0)
6638 Significance of gene expression of vascular endothelial growth factor and its receptors in therapeutic effect of the hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma (2009) (0)
A Case of Blind Loop Syndrome Caused by Infection with Giardia duodenalis Diagnosed with Double Balloon Enteroscopy (2014) (0)
Abstracts of Selected Papers Presented at the 28th Annual Meeting of the Japanese Society of Gastroenterology Kanazawa, Japan, October 1–3,1986 (2007) (0)
[Mutation in core and pre-core amino acid sequences of hepatitis B virus correlate with fulminant and severe hepatitis]. (1993) (0)
Immuno-electronmicroscopical study of the delta antigen in liver from an HBsAg carrier. (1985) (0)
[The factors associated with pathology, treatment and prognosis of chronic hepatitis B]. (2011) (0)
Subject Index Vol. 47, 2004 (2004) (0)
Evaluation of Exocrine and Endocrine Pancreatic Function in Patients With Pancreatic Stones Who Were Treated by Extracorporeal Shock Wave Lithotripsy and Endoscopic Therapy (2009) (0)
Role of Autoimmunity in Patients Transplanted for Acute Liver Failure of Unknown Origin: A Clinical and Graft Biopsy Analysis (2020) (0)
P556 Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease (2013) (0)
Suspicion of superior mesenteric artery syndrome in a patient with severe gastric dilatation after catheter ablation. (2015) (0)
Effects of Let-7c on the processing of hepatitis B virus associated liver diseases (2022) (0)
Prospective study of interferon (IFN) therapy for compensated cirrhotic patients with chronic hepatitis, c by monitoring serum hepatitis of virus (HCV) RNA (1998) (0)
Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of biliary disease. (2008) (0)
[Pulmonary nocardiosis associated with the treatment of severe liver injury]. (2014) (0)
B-RTO for Gastric Varices (2013) (0)
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Yoshiyuki NaraharaHidenori KanazawaChoitsu SakamotoHitoshi Maruyama • Osamu YokosukaSatoshi MochidaMasahito UemuraHiroshi FukuiYasukiyo Sumino • (2011) (0)
Sa1000 Natural History and Risk Factors of Carcinogenesis in the Iso-Enhanced Lesions on the Postvascular-Phase Sonograms in Chronic Liver Diseases (2015) (0)
Efficacy of endoscopic therapy of refractory benign biliary strictures due to chronic calcifying pancreatitis with multiple stenting (2016) (0)
Sa1178 Concomitant Use of Enteral Nutrition Therapy Increases Sustained Response to Infliximab in Patients With Crohn's Disease (2015) (0)
Compléments : Contrast-enhanced harmonic EUS of pancreatic schwannoma (2016) (0)
Impact of survival after moving onto the end-of-life care in patients with hepatocellular carcinoma (2017) (0)
[Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb]. (2010) (0)
Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein (1993) (0)
chronic hepatitis C carcinoma prevention for individual patients with Benefit of interferon therapy in hepatocellular (2004) (0)
Hepatitis C virus infection and antiviral treatment (1991) (0)
Development of a sandwich ELISA for the thrombin light chain identified by serum proteome analysis (2017) (0)
Anti-viral effect of recombinant interferon alfa-2a on hepatitis C virus (1993) (0)
M1242 Negative Capsule Endoscopy on Management of the Patients With Obscure Gastrointestinal Bleeding is Strongly Related to Anti-Platelet Agents Therapy (2010) (0)
Validity of pathological diagnosis for early colorectal cancer in genetic background (2023) (0)
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (2021) (0)
Contents Vol. 80, 2011 (2011) (0)
Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection q (2010) (0)
Reply to Xie S, Mai G. Comments on “Efficacy of Stone Density on Noncontrast Computed Tomography in Predicting the Outcome of Extracorporeal Shock Wave Lithotripsy for Patients With Pancreatic Stones” by Ohyama et al (2016) (0)
Tight Junction Protein Regulation is Important to Ameliorate the Inflammation of Colitis in Interleukin-10 Gene-Deficient (IL-10 Ko) Mice (2011) (0)
Schistosomiasis in Corsica and the pivotal role of travellers (2015) (0)
Analysis of DNA polymerase reaction products for detecting hepatitis B virus in serum--comparison with spot hybridization technique. (1985) (0)
[TTV infection in healthy subjects]. (1999) (0)
[High risk group of patients with hepatitis C virus infection developing hepatocellular carcinoma]. (1995) (0)
[Type C liver cirrhosis]. (2001) (0)
Tu1119 A Prospective Study of Prevalence of Eosinophilic Esophagitis and Alteration of Tight Junction Proteins in Patients With Gastroesophageal Reflux Disease (2015) (0)
Budd-Chiari syndrome due to hepatic vein obstruction without inferior vena cava obstruction (2008) (0)
Abstract 1184: Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism (SNP) array in gastrointestinal cancer (2010) (0)
Characteristics of conversion to 2nd line treatment in sorafenib-treated advanced hepatocellular carcinoma patients (2017) (0)
O2-8-1Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Japanese subgroup analysis of the phase III REACH trial (2015) (0)
Mo1610 Usability Assessment of Endoscopic Mucosal Resection With a CAP-Fitted Panendoscope for Superficial Epithelial Type of Sporadic Non-Ampullary Duodenal Adenoma/Carcinoma (2015) (0)
T2075 Comprehensive Analysis of Allelic Imbalance By Using High-Density Single Nucleotide Polymorphism (SNP) Array in Gastrointestinal Cancer (2008) (0)
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33 (2019) (0)
[Mutations in pre-C/C, pre-S/S and X regions of hepatitis B virus]. (2004) (0)
RESOLUTION OF LIVER FIBROSIS IN HEPATITIS C PATIENTS WITH INTERFERON : A NATIONAL SURVEY (2001) (0)
A case of primary biliary cirrhosis and autoimmune hepatitis overlap showing acute presentation and transient seropositivity for immunoglobulin G and anti-nuclear antibody (2013) (0)
[The clinical utility of the detection of hepatitis C virus genome by polymerase chain reaction]. (1991) (0)
[Expression of viral antigen in the early and the late phase of duck hepatitis virus infection]. (1988) (0)
[A case of antiphospholipid syndrome associated with Buerger's disease and portal hypertension]. (1995) (0)
[Devices for the safe performance of self-injection of interferon therapy for chronic hepatitis C]. (2006) (0)
Abstracts of selected papers presented at the 29th annual meeting of the Japanese society of gastroenterology Kofu, Japan, November 5–7, 1987 (1988) (0)
Response-Guided Treatment with an Ultrarapid Virological Response Creates the Future of Interferon-Free Treatment against Hepatitis C (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Osamu Yokosuka?

Osamu Yokosuka is affiliated with the following schools:

Chiba University

Osamu Yokosuka's Academic­Influence.com Rankings

Osamu Yokosuka's Degrees

Why Is Osamu Yokosuka Influential?

Osamu Yokosuka's Published Works

Published Works

What Schools Are Affiliated With Osamu Yokosuka?

Osamu Yokosuka's AcademicInfluence.com Rankings